explore -WSS

explore

author：comprehensive 2025-10-01 21:47:34 - browse：8

Dallas Mavericks owner Mark Cuban reacts during a timeout in the game against the Golden State Warriors at American Airlines Center on March 22, 2023 in Dallas, Texas. – opinion coverage from STAT — Tim Heitman/Getty Images

Mark Cuban, the Dallas Mavericks owner and “Shark Tank” star, has been making headlines recently with his direct-to-consumer venture, Cost Plus Drugs. The company sells generic prescription drugs and boasts more than 2 million members. As a family medicine specialist who has firsthand experience with American households’ dissatisfaction with the state of the nation’s prescription drug marketplace, I believe the enthusiasm for Cost Plus Drugs reveals an appetite for alternatives to the status quo in the pharmaceutical industry.

Cuban claims the reason behind the success of Cost Plus Drugs is the company’s decision to bypass pharmaceutical benefit managers — the negotiating agents insurance companies hire to negotiate big pharma’s prices down. But that might not be the case. Instead, its success appears to lie in its choice to collaborate with affordable generic drug manufacturers rather than the major pharmaceutical companies.

Last year, the Department of Health and Human Services found that between July 2021 and July 2022, major pharma companies raised the list price on more than 1,200 drugs by an average of 31 percent. That’s 23 percent more than the country’s overall inflation rate during the same period. Meanwhile, generic drug companies saved the U.S. roughly $2.6 trillion from 2012 to 2021, according to the Association for Accessible Medicines, a trade group representing generic drug manufacturers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Lawsuit highlights wrinkle for disputes over surprise medical bills

WSS

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

RSV injection headlines need to be accurate for good uptake

New oral drug delivery patch is modeled after octopus tentacles

2023 Nobel Prize in Medicine goes to Karikó and Weissman

Global cancer cases to surge 77% by 2050, WHO report says

Updated Covid vaccine has 54% effectiveness, new study suggests

focus

explore

leisure time

Moonlake's readout produced a cash windfall. Risks remain

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Cano Health’s bankruptcy is a warning for Medicare Advantage

How one medical school became remarkably diverse

Will an HIV vaccine ever be a reality?

In Memoriam: Notable people who died in 2023

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Heart attack and stroke risk calculators need revising

Lawsuit highlights wrinkle for disputes over surprise medical bills

focus

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Lawsuit highlights wrinkle for disputes over surprise medical bills

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Texas Medical Board asked to define abortion emergency exception

Congress extends some pandemic preparedness programs

Surgery pushed Ben Carson to fame

Wikipedia

focus

explore

focus